Related references
Note: Only part of the references are listed.Regadenoson
Karly P. Garnock-Jones et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
The Adenosine A2a Receptor Inhibits Matrix-induced Inflammation in a Novel Fashion
Kara A. Scheibner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Adenosine and adenosine receptors: Newer therapeutic perspective
S. Manjunath et al.
INDIAN JOURNAL OF PHARMACOLOGY (2009)
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A2A adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging
Gregory S. Thomas et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2009)
Regadenoson: A New Myocardial Stress Agent
Wael Al Jaroudi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases
G. Vass et al.
CURRENT MEDICINAL CHEMISTRY (2008)
The safety and tolerability of adenosine in patients with obstructive airways disease
William J. van Gaal et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease
Eliana Reyes et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2007)
Adenosine receptors as therapeutic targets
KA Jacobson et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging
RC Hendel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
